Bernadette Govaerts
About
In The Last Decade
Bernadette Govaerts
57 papers receiving 866 citations
Peers
Comparison fields: 5 of 157
- Molecular Biology 254
- Analytical Chemistry 206
- Food Science 188
- Spectroscopy 137
- Biomedical Engineering 126
Countries citing papers authored by Bernadette Govaerts
This map shows the geographic impact of Bernadette Govaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernadette Govaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernadette Govaerts more than expected).
Fields of papers citing papers by Bernadette Govaerts
This network shows the impact of papers produced by Bernadette Govaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernadette Govaerts. The network helps show where Bernadette Govaerts may publish in the future.
Co-authorship network of co-authors of Bernadette Govaerts
This figure shows the co-authorship network connecting the top 25 collaborators of Bernadette Govaerts. A scholar is included among the top collaborators of Bernadette Govaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernadette Govaerts. Bernadette Govaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 18 | |
| 4 | 5 | |
| 5 | NMR-based Metabolomics for New Target Discovery and Personalized Medicine: Application to Age-Related Macular Degeneration (AMD). | 1 |
| 6 | 28 | |
| 7 | From Metabolomics to Identification of a new therapeutic approach for Age-Related Macular Degeneration (AMD) | 1 |
| 8 | 20 | |
| 9 | 26 | |
| 10 | 7 | |
| 11 | 12 | |
| 12 | 39 | |
| 13 | 25 | |
| 14 | 23 | |
| 15 | Accuracy and precision : total error vs 4-6-30 | 1 |
| 16 | USING TOTAL ERROR AS DECISION CRITERION IN METHOD TRANSFER | 1 |
| 17 | Experimental design and observation for large systems - Discussion | 1 |
| 18 | Discussion in Atkinson A.C. : The usefulness of optimum experimental designs | 1 |
| 19 | SEPSOL : An experimental knowledge based front end developed using the FOCUS architecture and toolkit | 1 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.